SUBSCRIBE
SUBSCRIBE
News   Business

AstraZeneca PLC (JOBS) Drops Two Infinity Pharmaceuticals, Inc. Cancer Drugs

December 12, 2008 | 
1 min read
LONDON, Dec 11 (Reuters) - AstraZeneca has handed back rights to two experimental drugs discovered by Infinity Pharmaceuticals, one of which has already reached final-stage Phase III clinical testing.
Alliances Europe
AstraZeneca
MORE ON THIS TOPIC
Upward arrow on the background of the flag of China. Paper plane. Economic recovery. Copy space. Business. Background.
China
Deerfield bets up to $1.6B to snag autoimmune asset in China for Boulevard
June 30, 2026
 · 
1 min read
 · 
Annalee Armstrong
Solution Concept with Handshake on Chalkboard Background
Mergers & acquisitions
Zymeworks adds lung disease drug, royalty deals in nearly $1B pick up of Theravance
June 29, 2026
 · 
2 min read
 · 
Annalee Armstrong
Businessmen look at the city from the outskirts.
Pipeline
Moderna looks out to R&D ‘horizons’ as 2028 break-even goal looms
June 26, 2026
 · 
2 min read
 · 
Tristan Manalac
Big fish eats small, takeover of the company. Art collage.
M&A
Merck KGaA inks $11B Bio-Techne buyout to expand into cell therapy production
June 26, 2026
 · 
2 min read
 · 
Nick Paul Taylor